July 8, 2016
Vernalis completes its CCP-08 pivotal bioavailability studies
Vernalis has today announced the completion of the CCP-08 pivotal multiple-dose comparative bioavailability study.
Pharmaceuticals, Biotechnology and Life Sciences
Vernalis has today announced the completion of the CCP-08 pivotal multiple-dose comparative bioavailability study.